Earnings History Data for Synlogic (SYBX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Synlogic

Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and development platform. The company's pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases such as Urea Cycle Disorder and Phenylketonuria. In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of other diseases, such as liver disease, inflammatory and immune disorders and cancer. It is collaborating with AbbVie to develop Synthetic Biotic-based treatments for inflammatory bowel disease. Synlogic Inc., formerly known as Mirna Therapeutics Inc., is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		SYBX	Synlogic	17.00	-0.01	-0.18	0.00	Synlogic GAAP EPS of -$0.01 [11/12/2024 5:45 PM]	1.41	-0.05 (-3.42%)	0.0	0.0 (0.00%)	1.22 - 5.12	3,184	20,000	0
Synlogic GAAP EPS of -$0.01 [11/12/2024 5:45 PM] Synlogic Reports Third Quarter 2024 Financial Results [2024-11-12 04:35PM]
14-05-2024	PM		SYBX	Synlogic	21.00	-2.60	-0.80	0.00	Synlogic GAAP EPS of -$2.60 misses by $1.80 [5/14/2024 7:20 AM]	1.76	-0.04 (-1.94%)	1.71	-0.09 (-5.00%)	1.55 - 9.90	18,062	10,000	63,424
Synlogic GAAP EPS of -$2.60 misses by $1.80 [5/14/2024 7:20 AM]
19-03-2024	PM		SYBX	Synlogic	17.00	-1.71	-1.11	0.00	Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M [3/19/2024 7:13 AM]	1.76	-0.14 (-7.27%)	0.0	0.0 (0.00%)	1.55 - 11.02	110,935	40,000	0
Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M [3/19/2024 7:13 AM]
29-03-2023	PM		SYBX	Synlogic	41.00	-0.24	-0.26	0.00	Synlogic GAAP EPS of -$0.24 beats by $0.02, revenue of $0.11M misses by $0.12M [3/29/2023 6:44 AM]	0.6201	0.01 (1.32%)	0.60	-0.01 (-1.63%)	0.55 - 2.60	286,792	100,000	226
Synlogic GAAP EPS of -$0.24 beats by $0.02, revenue of $0.11M misses by $0.12M [3/29/2023 6:44 AM] Synlogic's metabolic disorder therapy gets EMA backing for orphan drug tag [3/28/2023 9:13 AM]
10-11-2022	PM		SYBX	Synlogic, Inc.	51.98	-0.25	-0.23	-0.29	Synlogic GAAP EPS of -$0.25 misses by $0.02, revenue of $0.7M beats by $0.61M [11/10/2022 8:45 AM]	0.65	-0.04 (-5.80%)	0.74	0.05 (7.23%)	0.65 - 3.00	145,713	100,000	3,510
Synlogic GAAP EPS of -$0.25 misses by $0.02, revenue of $0.7M beats by $0.61M [11/10/2022 8:45 AM] Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-10-22 06:59AM]
11-08-2022	PM	7:00 AM ET (Aug 11)	SYBX	Synlogic, Inc.	73.06	-0.22	-0.23	-0.28	Synlogic GAAP EPS of -$0.22 beats by $0.01, revenue of $0.15M beats by $0.03M [8/11/2022 7:10 AM]	1.08	0.10 (10.20%)	1.09	0.11 (11.22%)	0.83 - 4.04	621,125	150,000	10,236
Synlogic Q2 2022 Earnings Preview [8/10/2022 1:00 PM] Synlogic GAAP EPS of -$0.22 beats by $0.01, revenue of $0.15M beats by $0.03M [8/11/2022 7:10 AM] Synlogic, Ginkgo Bioworks develop SYNB2081 to treat gout [8/11/2022 7:49 AM] Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks [Aug-11-22 07:05AM] Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-11-22 06:58AM]
12-05-2022	PM	7:00 AM ET (May 12)	SYBX	Synlogic, Inc.	92.76	-0.22	-0.23	-0.36	Synlogic GAAP EPS of -$0.22 beats by $0.06, revenue of $0.24M beats by $0.08M [5/12/2022 7:09 AM]	1.07	-0.18 (-14.40%)	1.20	-0.05 (-4.00%)	1.02 - 4.54	454,196	90,000	157
Synlogic Q1 2022 Earnings Preview [5/11/2022 12:40 PM] Synlogic GAAP EPS of -$0.22 beats by $0.06, revenue of $0.24M beats by $0.08M [5/12/2022 7:09 AM] Synlogic Reports First Quarter 2022 Financial Results and Provides Business Update [May-12-22 07:00AM] Synlogic, Inc. (SYBX) Reports Q1 Loss, Misses Revenue Estimates [May-12-22 08:35AM] Synlogic (NASDAQ:SYBX shareholders incur further losses as stock declines 28% this week, taking three-year losses to 85% [May-12-22 10:51AM]
17-03-2022	PM	7:00 AM ET (Mar 17)	SYBX	Synlogic, Inc.	135.24	-0.21	-0.27	-0.39	Synlogic GAAP EPS of -$0.21 beats by $0.06, revenue of $0.59M beats by $0.36M [3/17/2022 7:09 AM]	2.01	-0.13 (-6.07%)	0.0	0.0 (0.00%)	1.39 - 5.10	145,355	126,826	0
Synlogic Q4 2021 Earnings Preview [3/16/2022 10:37 AM] Synlogic GAAP EPS of -$0.21 beats by $0.06, revenue of $0.59M beats by $0.36M [3/17/2022 7:09 AM] Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-17-22 07:00AM] Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates [Mar-17-22 08:25AM]
10-11-2021	PM	6:30 AM ET (Nov 10)	SYBX	Synlogic, Inc.	184.60	-0.29	-0.29	-0.36	Synlogic EPS in-line, beats on revenue [11/10/2021 7:15 AM]	2.66	-0.03 (-1.12%)	2.69	0.0 (0.00%)	2.02 - 5.11	202,800	140,000	729
Synlogic Q3 2021 Earnings Preview [11/9/2021 10:14 AM] Synlogic EPS in-line, beats on revenue [11/10/2021 7:15 AM] Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria [Nov-09-21 07:00AM] Synlogic Reports Third Quarter Financial Results and Provides Business Update [Nov-10-21 07:00AM] Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting [Nov-10-21 07:00AM] Synlogic, Inc. (SYBX) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 08:35AM]
12-08-2021	PM	6:30 AM ET (Aug 12)	SYBX	Synlogic, Inc.	159.21	-0.28	-0.29	-0.44	Synlogic EPS beats by $0.03, beats on revenue [8/12/2021 6:32 AM]	2.87	-0.05 (-1.71%)	2.87	-0.05 (-1.71%)	1.78 - 5.11	74,279	150,000	9,644
Synlogic EPS beats by $0.03, beats on revenue [8/12/2021 6:32 AM] Synlogic Reports Second Quarter Financial Results and Provides Business Update [Aug-12-21 06:30AM] Synlogic, Inc. (SYBX) Reports Q2 Loss, Tops Revenue Estimates [Aug-12-21 08:15AM]
13-05-2021	PM	6:30 AM ET (May 13)	SYBX	Synlogic, Inc.	158.98	-0.36	-0.39	-0.46	Synlogic EPS beats by $0.03 [5/13/2021 6:32 AM]	3.16	-0.10 (-3.07%)	3.13	-0.13 (-3.99%)	1.78 - 5.11	391,497	1,070,000	1,334
Synlogic EPS beats by $0.03 [5/13/2021 6:32 AM] Synlogic, Inc. to Host Earnings Call [May-13-21 06:30AM] Synlogic Reports First Quarter Financial Results and Provides Business Update [May-13-21 06:30AM]
25-03-2021	PM	6:30 AM ET (Mar 25)	SYBX	Synlogic, Inc.	172.28	-0.39	-0.40	-0.37	Synlogic EPS beats by $0.02 [3/25/2021 6:32 AM]	3.91	0.03 (0.77%)	3.55	-0.33 (-8.51%)	1.51 - 5.11	4,868,174	330,000	4,913
Synlogic’s oral therapy for enteric hyperoxaluria advances to proof-of-concept study [3/24/2021 4:38 PM] Synlogic EPS beats by $0.02 [3/25/2021 6:32 AM] Synlogic pares gains after reaching session high on bullish SVB Leerink note [3/25/2021 2:19 PM] Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria [Mar-24-21 04:05PM] Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update [Mar-25-21 06:30AM] Synlogic, Inc. to Host Earnings Call [Mar-25-21 06:30AM] The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut [Mar-25-21 07:58AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	SYBX	Synlogic, Inc.	63.55	-0.36	-0.47	-0.39	Synlogic EPS beats by $0.10 [11/5/2020 6:40 AM]	2.00	0.12 (6.38%)	2.03	0.15 (7.98%)	1.35 - 3.46	302,328	162,227	80,777

06-08-2020	PM	6:00 AM ET (Aug 6)	SYBX	Synlogic, Inc.	73.56	-0.44	-0.46	-0.45	Synlogic EPS beats by $0.02, beats on revenue [8/6/2020 7:09 AM]	2.22	-0.11 (-4.72%)	2.38	0.05 (2.15%)	1.35 - 5.82	113,094	133,902	1,469